A balloon dilation catheter

By setting multiple independent balloons and drug coatings on the balloon dilation catheter, combined with injection and perfusion ports, the problems of blood flow obstruction and vascular retraction in the prior art are solved, achieving better vasodilation and drug release effects.

CN224975591UActive Publication Date: 2026-11-17ZIGONG THIRD PEOPLES HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202521328384.X
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-06-26
Publication Date
2026-11-17
Estimated Expiration
2035-06-26

AI Technical Summary

Technical Problem

Existing balloon dilation catheters can easily completely block blood flow during dilation, leading to postoperative hyperperfusion syndrome and the risk of vascular elastic recoil or restenosis, thus affecting the surgical outcome.

Method used

The catheter body is designed with multiple independent balloons circumferentially arranged at the distal end. After expansion, the balloons are evenly dispersed in a petal shape, allowing blood flow to pass through. They are expanded through independent filling cavities. The surface of the balloons is provided with protrusions and a drug coating. The catheter body is provided with injection holes and perfusion holes to achieve precise treatment and self-perfusion.

Benefits of technology

It avoids complete blood flow blockage, reduces the risk of postoperative hyperperfusion syndrome, prolongs balloon dilation time, improves vasodilation effect, reduces the possibility of vascular elastic recoil and restenosis, and achieves precise drug release.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224975591U_ABST
    Figure CN224975591U_ABST
Patent Text Reader

Abstract

This utility model relates to the field of medical device technology and discloses a balloon dilation catheter, including a catheter body with a delivery cavity along its central axis. Multiple balloons are evenly distributed circumferentially at the distal end of the catheter body. The distal ends of the balloons are sealed to the outer wall of the catheter body, and the proximal ends of the balloons are sealed to the outer wall of the catheter body and communicate with an filling cavity within the catheter body wall. Multiple filling cavities are evenly distributed circumferentially along the catheter body, each filling cavity connecting to one balloon. The multiple balloons and filling cavities are not interconnected. After dilation, the multiple balloons form a uniformly dispersed petal shape. In this utility model, the multiple balloons, after dilation, form a uniformly dispersed petal shape, with gaps between adjacent balloons allowing blood flow. This avoids the problem of postoperative hyperperfusion syndrome caused by complete blood flow blockage after balloon dilation, while also allowing for a longer balloon inflation time, better ensuring the vascular dilation effect of the balloons, reducing postoperative vascular elastic recoil, and improving the vascular dilation effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of medical device technology, and specifically discloses a balloon dilation catheter. Background Technology

[0002] Balloon dilation is a fundamental interventional treatment for cardiac and intracranial vascular stenosis. A balloon is inserted through a catheter to the narrowed area, inflated, and its expansion force opens the narrowed blood vessel lumen, increasing its diameter and restoring blood flow. This directly relieves the mechanical narrowing of the blood vessel, restores normal blood perfusion, and alleviates insufficient blood supply to tissues and organs caused by vascular stenosis. This method is simple to perform and suitable for mild stenosis, but there is a risk of elastic recoil or restenosis, requiring careful control of the dilation pressure and duration.

[0003] Existing balloon dilation catheters typically have a single balloon placed at the distal end of the catheter. During balloon dilation and maintenance, blood flow is completely blocked. If the blood flow is blocked for too long, it can lead to postoperative hyperperfusion syndrome. If the blocking time is insufficient (insufficient balloon dilation time), there is a risk of vascular elastic recoil or restenosis, which affects the surgical outcome. Utility Model Content

[0004] To address the shortcomings of the existing technology, this invention provides a balloon dilation catheter with a simple structure that does not completely block blood flow but ensures vasodilation effect.

[0005] To achieve the above-mentioned technical objectives, the technical solution adopted by this utility model is as follows:

[0006] A balloon dilation catheter includes a catheter body with a delivery cavity along its central axis. Multiple balloons are evenly distributed circumferentially at the distal end of the catheter body. The distal ends of the balloons are sealed to the outer wall of the catheter body, and the proximal ends of the balloons are sealed to the outer wall of the catheter body and communicate with an filling cavity inside the catheter body wall. Multiple filling cavities are evenly distributed circumferentially along the catheter body, and each filling cavity communicates with one balloon. The multiple balloons are not interconnected with each other, and the multiple filling cavities are not interconnected with each other. After dilation, the multiple balloons are evenly dispersed in a petal shape.

[0007] As a preferred technical solution, the distal end of the catheter body has a radially formed injection port on the tube wall between adjacent balloons, and the injection port penetrates the tube wall and communicates with the delivery cavity.

[0008] As a preferred technical solution, the number of balloons is the same as the number of inflation cavities, and there is a one-to-one correspondence between balloons and inflation cavities.

[0009] As a preferred technical solution, the number of balloons is 4 to 8, and the number of inflation cavities is 4 to 8.

[0010] As a preferred technical solution, the balloon surface is provided with a number of protrusions, the protrusions are located at the position on the balloon surface farthest from the central axis of the catheter body, and the protrusions are arranged in a straight line along the direction parallel to the central axis of the catheter body.

[0011] As a preferred technical solution, the protrusion is solid, nipple-shaped, or cone-shaped.

[0012] As a preferred technical solution, the smooth area of ​​the balloon surface is coated with a drug coating.

[0013] As a preferred technical solution, the distal end of the catheter body is provided with at least one infusion hole at a distance from the proximal end of the balloon. The infusion hole communicates with the delivery cavity and avoids the filling cavity.

[0014] As a preferred technical solution, the catheter body is provided with first contrast rings at the distal and proximal ends of the balloon.

[0015] As a preferred technical solution, a second contrast ring is provided on the catheter body near the proximal end of the infusion port.

[0016] The beneficial effects of this utility model are as follows:

[0017] The present invention relates to a balloon dilation catheter, in which multiple balloons are arranged circumferentially at the distal end of the catheter body. After inflation and expansion, the multiple balloons are arranged in a uniformly dispersed petal shape. There are gaps between adjacent balloons to allow blood flow, avoiding the problem of postoperative hyperperfusion syndrome caused by complete blockage of blood flow after balloon dilation. At the same time, it allows for a longer balloon inflation time, better ensuring the vascular dilation effect of the balloon, reducing postoperative vascular elastic recoil, and improving the vascular dilation effect.

[0018] The balloon dilation catheter of this invention allows each balloon to expand through an independent filling cavity, with no interference between balloons. This enables targeted enhanced dilation based on individual cases, resulting in more effective treatment.

[0019] The balloon dilation catheter of this invention features a balloon surface with protrusions that apply targeted pressure to the lesion to ensure dilation, while the smooth section between adjacent protrusions allows stress relief from the lesion, preventing tearing of the vascular intima during dilation. The smooth section of the balloon surface is coated with a drug that allows for better contact with the lesion after dilation, achieving precise drug release and reducing the risk of restenosis.

[0020] The balloon dilation catheter of this invention features an injection port for convenient delivery of medication to the lesion site via the delivery chamber during surgery as needed; and an irrigation port for allowing blood to flow through the delivery chamber to distal vessels, achieving self-perfusion and further preventing postoperative hyperperfusion syndrome. Attached Figure Description

[0021] To more clearly illustrate the technical solutions of the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of this application and should not be regarded as a limitation of the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.

[0022] Figure 1 This is a schematic diagram of the overall structure of an embodiment of the present utility model;

[0023] Figure 2 yes Figure 1 Schematic diagram of the cross section of AA;

[0024] Figure 3 yes Figure 1 A schematic diagram of the cross-section of BB;

[0025] Figure 4 yes Figure 1 A longitudinal sectional view.

[0026] Reference numerals: 1-Catheter body, 11-Delivery cavity, 12-Filling cavity, 13-Injection port, 14-Infusion port, 2-Balloon, 21-Protrusion, 3-First contrast ring, 4-Second contrast ring, 5-Guide wire. Detailed Implementation

[0027] To make the objectives, technical solutions, and advantages of the embodiments of this application clearer, the technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, not all embodiments. The components of the embodiments of this application described and shown in the accompanying drawings can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiments of this application provided in the accompanying drawings is not intended to limit the scope of the claimed application, but merely represents selected embodiments of this application. All other embodiments obtained by those skilled in the art based on the embodiments of this application without creative effort are within the scope of protection of this application.

[0028] A type of balloon dilation catheter, such as Figures 1-4 As shown, the catheter includes a catheter body 1, which has a delivery cavity 11 along its central axis. Multiple balloons 2 are evenly distributed around the distal end of the catheter body 1. The distal end of the balloons 2 is sealed to the outer wall of the catheter body 1, and the proximal end of the balloons 2 is sealed to the outer wall of the catheter body 1 and communicates with the filling cavity 12 inside the catheter body 1. Multiple filling cavities 12 are evenly distributed around the circumference of the catheter body 1. Each filling cavity 12 communicates with one balloon 2. The multiple balloons 2 are not connected to each other, and the multiple filling cavities 12 are not connected to each other.

[0029] Preferably, the number of balloons 2 is the same as the number of inflation cavities 12, with a one-to-one correspondence between balloons 2 and inflation cavities 12. More preferably, the number of balloons 2 is 4 to 8, and the number of inflation cavities 12 is 4 to 8. Figure 2 , Figure 3 In the embodiment shown, there are 8 balloons 2 and 8 inflation cavities 12.

[0030] The balloon dilation catheter of this invention has multiple balloons 2 that, after dilation, are evenly dispersed in a petal shape. There are gaps between adjacent balloons 2 to allow blood flow, thus avoiding the problem of postoperative hyperperfusion syndrome caused by complete blockage of blood flow after balloon 2 dilation.

[0031] Furthermore, the surface of the balloon 2 is provided with a plurality of protrusions 21. Preferably, the protrusions 21 are located at the position furthest from the central axis of the catheter body 1 on the surface of the balloon 2. The protrusions 21 are arranged in a straight line along a direction parallel to the central axis of the catheter body 1. Preferably, the protrusions 21 can be solid papillary or conical. The protrusions 21 on the surface of the balloon 2 are used to apply targeted pressure to the lesion site when the balloon 2 is inflated, ensuring the expansion effect. At the same time, the smooth section between adjacent protrusions 21 can release the stress of the lesion plate and avoid tearing of the vascular intima during expansion.

[0032] Furthermore, the smooth section of the balloon 2 surface is coated with a drug coating. The protrusions 21 allow the drug to better contact the lesion site and achieve precise release after the lesion area expands and ruptures. The drug coating can be paclitaxel, or other drugs with anti-proliferative and anti-inflammatory effects, such as rapamycin or sirolimus. The drug can be coated onto the balloon surface using ultrasonic spraying, electrostatic spraying, or other techniques to make the drug coating more uniform and durable.

[0033] Preferably, the catheter body 1 is provided with a first imaging ring 3 at the distal end and proximal end of the balloon 2 to enhance the visibility of the catheter body 1 under X-ray, so as to facilitate the determination of the insertion of the catheter body 1 to the designated position.

[0034] Furthermore, the distal end of the catheter body 1 has a radially formed injection port 13 on the wall between any two adjacent balloons 2. The injection port 13 penetrates the tube wall and communicates with the delivery chamber 11. The injection port 13 facilitates the delivery of medication to the lesion site through the delivery chamber 11 as needed during the procedure. The medication flows through the delivery chamber 11 and the injection port 13 to the designated site, achieving precise medication delivery.

[0035] Furthermore, at least one infusion port 14 is provided at the distal end of the catheter body 1 on the proximal side of the balloon 2, spaced apart from the balloon 2. The infusion port 14 communicates with the delivery chamber 11 and avoids the filling chamber 12. Preferably, a second radiopaque ring 4 is provided on the catheter body 1 near the proximal end of the infusion port 14.

[0036] During the procedure, guided by the guidewire 5, the distal end of the catheter body 1 is placed into the lesion site. Gas or liquid is infused into the balloon 2 through the filling chamber 12 to inflate the balloon 2. Then, the guidewire 5 is retracted to the position of the second contrast ring 4, exposing the infusion port 14. Blood from the proximal end enters the delivery chamber 11 through the infusion port 14 and flows out from the distal opening of the catheter body 1 through the delivery chamber 11, allowing the blood to flow normally to the distal blood vessel, achieving self-perfusion, further avoiding the occurrence of postoperative hyperperfusion syndrome, and allowing the balloon inflation time to be prolonged, better ensuring the balloon's vasodilatory effect and reducing postoperative vascular elastic recoil.

[0037] Of course, there may be other embodiments of this utility model. Without departing from the spirit and essence of this utility model, those skilled in the art can make various corresponding changes and modifications based on this utility model, but these corresponding changes and modifications should all fall within the protection scope of the appended claims of this utility model.

Claims

1. A balloon dilation catheter, comprising a catheter body (1), characterized in that: The catheter body (1) has a delivery cavity (11) along its central axis. Multiple balloons (2) are evenly distributed around the distal end of the catheter body (1). The distal end of the balloons (2) is sealed and connected to the outer wall of the catheter body (1). The proximal end of the balloons (2) is sealed and connected to the outer wall of the catheter body (1) and communicates with the filling cavity (12) inside the catheter body (1). Multiple filling cavities (12) are evenly distributed around the circumference of the catheter body (1). Each filling cavity (12) communicates with one balloon (2). Multiple balloons (2) are not connected to each other. Multiple filling cavities (12) are not connected to each other. After expansion, multiple balloons (2) are evenly dispersed in a petal shape.

2. The balloon dilation catheter according to claim 1, characterized in that: The distal end of the catheter body (1) is provided with a radial injection hole (13) on the tube wall between adjacent balloons (2), and the injection hole (13) penetrates the tube wall and communicates with the delivery cavity (11).

3. The balloon dilation catheter according to claim 2, characterized in that: The number of balloons (2) is the same as the number of filling cavities (12), and there is a one-to-one correspondence between balloons (2) and filling cavities (12).

4. The balloon dilation catheter according to claim 3, characterized in that: The number of balloons (2) is 4 to 8, and the number of filling cavities (12) is 4 to 8.

5. The balloon dilation catheter according to claim 1, characterized in that: The balloon (2) has a number of protrusions (21) on its surface. The protrusions (21) are located at the position furthest from the central axis of the catheter body (1) on the surface of the balloon (2). The protrusions (21) are arranged in a straight line along the direction parallel to the central axis of the catheter body (1).

6. The balloon dilation catheter according to claim 5, characterized in that: The protrusion (21) is solid, papillary, or conical.

7. The balloon dilation catheter according to claim 5, characterized in that: The smooth area of ​​the balloon (2) is coated with a drug coating.

8. The balloon dilation catheter according to claim 1, characterized in that: The distal end of the catheter body (1) is located on the proximal side of the balloon (2) and is provided with at least one infusion hole (14) at a distance from the balloon (2). The infusion hole (14) communicates with the delivery chamber (11) and avoids the filling chamber (12).

9. The balloon dilation catheter according to claim 1, characterized in that: The catheter body (1) is provided with first contrast rings (3) at the distal and proximal ends of the balloon (2).

10. The balloon dilation catheter according to claim 8, characterized in that: A second imaging ring (4) is provided on the catheter body (1) near the end of the infusion hole (14).